Efficacy, Doses, Side Effects, and Cost of the Sputnik V Vaccine

COVID-19 SARS-CoV-2 is causing a pandemic, and a vaccine can help protect individuals and contain the problem.

Efficacy, Doses, Side Effects, and Cost of the Sputnik V Vaccine
Efficacy, Doses, Side Effects, and Cost of the Sputnik V Vaccine

Eventually, the vaccine-infected cells are destroyed by the very immunity they are designed to evoke. Recombinant adenoviruses (rAD) have been used widely as vaccine vectors due to their quality to accommodate large genetic payloads and, although unable to replicate, they trigger the intuitive immunity sensors sufficiently to make sure a robust immune system in nature.

A heterologous recombinant adenovirus approach is shared with the chimpanzee adenovirus (ChAdOx) vectored COVID-19 vaccine by Oxford/AstraZeneca, Adenovirus 26 (Ad26) vectored COVID-19 vaccine by the Johnson & Johnson, and the Adenovirus 5 (Ad5) vectored COVID-19 vaccine by CanSinoBIO-Beijing Institute of Biotechnology.

The Sputnik V Vaccine has yet to receive approval for emergency use (EUL) from the World Health Organization (WHO) and European Medicines Agency (EMA). The WHO Emergency Use Listing Procedure (EUL) will initiate widespread distribution and make it eligible for COVAX (COVID-19 Vaccines Global Access) initiative that can provide equitable access to COVID-19 vaccine doses for Low-Income Countries. In spite of not having WHO and EMA emergency use approval, the Sputnik V Vaccine is already registered in more than 70 countries simultaneously these countries have started administering the vaccine to their people. 

During phase 3 clinical trials, the Sputnik Light vaccine reported 73.6% efficacy in preventing moderate to severe COVID-19 infection. As per Russia’s mass vaccination program between 5 December 2020 and 15 April 2021 single-dose vaccine, Sputnik Light reported 79.4% efficacy in preventing symptomatic COVID-19 infection.

On 21st June 2021 under the new vaccination policy Shri Narendra Damodardas Modi, Prime Minister of INDIA announced all above the age of 18 would get free vaccines. The two-dose Sputnik V vaccine is currently administered in INDIA free of cost to the general population through the Centre allocated to states and union territories based on criteria such as disease burden, population, and vaccination progress.

The government of India is taking all necessary steps to ensure that the nation is prepared to face the challenge and threat posed by the growing contagion of COVID-19. The exemplary groundwork and precaution advisory by the Government have helped in containing the spread of the virus in our country. At present, the priority is to make COVID -19 vaccine available to all, ensuring vaccine traceability and beneficiary tracking from production to last-mile administration.

In order to control the spread of coronavirus, countries throughout the world are developing various vaccines so that the lives of people can be back to normal. So Russia has also developed a vaccine called Sputnik. This vaccine will be approved by a European medical agency soon. Citizens can buy this vaccine soon. Today through this article we are going to give you complete details regarding Sputnik Vaccine Registration. By reading this article you will get to know complete details regarding this vaccine like its efficacy, side effects, appointment schedule, center list, dosage gap, prices, etc. So if you are interested to register for getting Vaccinated with the Sputnik vaccine then you are requested to read this article thoroughly.

Side Effects Of Sputnik Vaccine

Common side effects of the Sputnik vaccine are as follows:-

  • Nausea
  • Vomiting
  • Fever
  • Chills
  • Muscle ache
  • Headache
  • Joint pain
  • Fatigue

Benefits And Features Of Sputnik Vaccine Registration

  • Sputnik Vaccine has developed in Russia
  • This vaccine provides protection against covid-19 as-it-is adenovirus-based vaccine
  • This vaccine uses a weakened virus to deliver a small part of the pathogen in order to stimulate an immune response
  • The family research Institute of epidemiology and microbiology of Russia has developed this vaccine
  • Dr. Reddy’s laboratory in India will manufacture Sputnik Vaccine
  • An agreement has been signed between India and Russia and according to this agreement Russia is going to provide 850 million doses of this vaccine to India
  • The efficacy rate of this Vaccine is 91.6%
  • The registration process will begin soon
  • The estimated price of this vaccine will be around Rs 700 to Rs 800
  • In government vaccination centers the vaccine will be provided free of cost
  • Two doses will be provided with a gap of 21 days which is 3 weeks
  • Once the vaccine is available on the market the information about the number of shots will be available
  • After 18 days of getting this vaccine, the immune system starts increasing in the human body
  • This vaccine is said to be most effective as compared to other vaccines
  • For every strain of virus, the Sputnik vaccine is effective
  • This vaccine stops the spike of virus protein to build in the body which weakens the virus
  • All the citizens whose age is above 18 years can take this vaccine

Eligibility Criteria And Required Documents Of Sputnik Vaccine Registration

  • Applicant must be a permanent resident of India
  • The age of the applicant must be 18 years or more
  • Aadhar card
  • Residence proof
  • Age proof
  • Passport size photograph
  • Mobile number

Sputnik vaccine is developed in Russia that provides protection against covid-19 it is an adenovirus-based vaccine. This vaccine uses a weakened virus to deliver a small part of the pathogen in order to stimulate an immune response. Russia’s Gamaleya research institute of epidemiology and microbiology has developed this vaccine. This vaccine will be manufactured by Dr. Reddy’s laboratories in India. An agreement of providing 850 million doses has been signed between India and Russia. The efficacy rate of the sputnik vaccine is 91.6%. The registration process will start soon. The estimated price of this vaccine will be around Rs 700 to Rs 800. It may be provided free of cost in government vaccination centres. The registration process to get vaccinated by Sputnik Vaccinewill begin soon.

Sputnik is a single-dose medicine but some experts are of opinion that in India 2 doses will be provided with a gap of 21 days which is 3 weeks. The information about the number of shots will be available once the vaccine is available on the market. After 18 days of getting this vaccine, the immune system starts increasing in the human body. This vaccine is proven to be most effective than any other vaccine. This vaccine has been found to be effective for every strain of the virus. It stops the spike of virus protein to build in the body which weakens the virus. All Those citizens whose age is above 18 years can take this vaccine.

The main objective of Sputnik Vaccine Registration is to vaccinate the citizens of India so that the spread of coronavirus can be contained. This registration will be done through online means. Citizens are not required to visit any government offices in order to register themselves. They are just required to visit the official website and from the official website, they can register themselves for getting the vaccine. This will save a lot of time and money and will also bring transparency to the system. Online registration will also enable the government to record the data of vaccinated citizens.

Recently an agreement has been signed between Russia and India and according to this agreement, Russia is going to provide 850 million doses of the sputnik vaccine. The registration procedure has not started yet. As soon as the vaccines become available in the market the registration process will also begin. We are going to provide you with complete details regarding the registration procedure to get the Sputnik vaccine through this article. So kindly keep in touch with us in the future.

As per recent research, a third dose or booster dose of the covid vaccine will help in fighting new variants of the SARS-CoV-2 virus. COVAXIN, COVISHIELD, and SPUTNIK-V's 1st dose are currently available as a booster shot in India, all persons aged 18 years and above can take a booster dose if they are fully vaccinated. A fully vaccinated person who has had 2 shots of covid vaccine can take a COVID-19 booster shot 3 to 6 months after their second dose.

Those who are looking to register for Covid-19 vaccination can visit the website and can start doing self-registration. A person can register with his / her Mobile no. and Photo ID proof (Aadhar Card, Driving License, PAN Card, Passport, Pension Passbook, NPR Smart Card, Voter ID) with a total of 4 members including him/her for vaccination. Yes, covid vaccines in India are absolutely safe. Currently, Covishield, Covaxin, and Sputnik-V two-dose vaccines are administered in India. Covovax and Corbevax will soon be available to the public. As per the recent data, those who all are fully vaccinated are safe against the coronavirus.

Among the hospitals that have rolled out the vaccine in the city include Apollo and Fortis hospitals. “Indraprastha Apollo has started the administration of the Sputnik V vaccine for the public in a staged manner from June 30th,” a spokesperson of Apollo Hospitals said, adding that over 1,000 people have been administered the vaccine so far.

In a country where there are a huge population, mass gatherings, ceremonies, and traditions, maintaining social distancing to safeguard one from contracting the virus is not practically possible. Moreover, it is impossible to wear a mask all day, every day. The impact of getting infected is worse than any side effect of the vaccine. Therefore, we urge you to join us in this vaccination drive and get vaccinated to prevent the next wave.

Out of 136.6 crore people in India, only 7.51 crore are fully-vaccinated. That’s a mere 5.7% of the total population. The reason why people hesitate to get vaccinated can be due to fear of adverse effects, misleading social media posts/news, misinterpretation of data, lack of awareness about the current status of the virus and vaccine, negligence of responsibility, etc. But, there is enough evidence that vaccination against COVID-19 is entirely safe and that only 1 in 10,00,000 experience adverse effects. 

During the second wave of COVID-19, MIOT Hospitals and many other hospitals nationwide saw people in their 20s, 30s, and 40s fall prey to the virus. Many develop COVID-Pneumonia due to excessive infiltration and blockage of the lungs. COVID-Pneumonia is a severe infection that affects the lungs adversely, delays recovery, and reduces the chance of positive outcomes of the disease. One of the main reasons why the second wave did not hit those in their 60s is because most of them were vaccinated against the virus. Notably, those in the 45-50 age group, who were vaccinated with two doses, experienced only mild symptoms as opposed to severe lung infiltration in those who did not take the vaccine. There was no report of COVID-Pneumonia in the fully vaccinated group and the duration of hospital stay was reduced. Vaccine, when both the doses are administered ensures that even with co-morbidities like diabetes, hypertension, and other chronic diseases, the infection does not affect the lungs.

The Russian COVID-19 vaccine – Sputnik V was recently approved for use in India and 69 other countries worldwide. MIOT Hospitals is one of the very few centers in the country to make the Sputnik V COVID-19 vaccine available to the common public. It is similar to Covishield in terms of the virus used for delivering the spike proteins. But, instead of using one engineered adenovirus, Sputnik V uses different adenoviruses, for the first and second doses separated by 21 to 84 days. The two adenoviruses have slightly different methods of introducing the viral proteins into the human body thereby increasing its protective effect. The efficacy rate of the Sputnik V COVID-19 vaccine as published in a Lancet journal and covered by the BBC is 91.6%. The common concern among people in recent times is how effective could the vaccine be against the mutant delta strain of the virus. The drop in efficacy of the vaccine against the delta variant is negligible.
The Oxford–AstraZeneca COVID-19 vaccine- Covishield was the first vaccine approved by the Indian Government. MIOT Hospitals was among the first private hospitals in India to bring the Covishield vaccine to the general public. It is administered in two doses separated by 84 days – a first standard dose followed by a booster dose. The efficacy rate of the vaccine is 70% and can scale up to 91% following administration of both doses. The vaccine evokes a tolerable immune response, successfully resulting in antibody production and elimination of the live virus. It is effective in preventing moderate to severe forms of the illness caused by the delta variant also.
Name Of The Scheme Sputnik Vaccine Registration
Launched By Government Of India
Efficacy 91.6%
Beneficiary Citizens Of India
Objective To Provide Vaccine
Official Website https://sputnikvaccine.com/
Year 2022
Price Rs 700 To Rs 800
Dosage Gap 21 Days